Skip to content
Lower risk Drug recall · FDA · Published January 16, 2019

KRS Global Recalls NORepinephrine IV Bags Due to Label Mix-Up

KRS Global recalls NORepinephrine 16 mg IV bags with labeling mix-up. This affects specific lot numbers and may cause confusion in medical use. Contact for details.

🇺🇸 FDA recall #D-1078-2019DrugKRS Global ›
Take action

Contact the company

Recalling firmKRS Global Biotechnology, Inc791 Park of Commerce Blvd Ste 600 · Boca Raton, FL 33487-3633
✎ GovInfoNow plain-language explainer

What happened, in plain English

KRS Global is recalling NORepinephrine 16 mg IV bags that have a labeling mix-up. This could lead to incorrect medication use in medical settings, so healthcare providers should verify the product. Read more at govinfonow.com/recall/39240-krs-global-recalls-norepinephrine-iv-bags-due-to-label-mix.

Source Summary by GovInfoNow · govinfonow.com/recall/39240-krs-global-recalls-norepinephrine-iv-bags-due-to-label-mix · Updated October 5, 2026 · FDA enforcement record: FDA #D-1078-2019

Cite this page

“KRS Global Recalls NORepinephrine IV Bags Due to Label Mix-Up.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39240-krs-global-recalls-norepinephrine-iv-bags-due-to-label-mix. Based on FDA recall #D-1078-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1078-2019%22&limit=1).

Why it’s dangerous

The labeling mix-up means the product might be confused with another medication. This could lead to incorrect dosing or administration in medical settings, but it does not cause immediate harm.

Who’s affected

Healthcare providers using the recalled NORepinephrine IV bags for medical treatments. Patients receiving this medication under a doctor's supervision are not directly affected.

How to tell if you have this one

Check for the NDC code 3321678343 and lot number 12112018@24. The product was sold with an expiration date of 01/25/2019.

  • Brand
    KRS Global
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the USA
Recall numberProduct, codes & lotsQuantity
D-1078-2019NORepinephrine 16 mg added to 0.9% Sodium Chloride (PF), 16 mg / 250 mL, 250 mL IV bag, Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC 3321678343; Lot: 12112018@24 Exp. 01/25/2019190 250 mL bags
D-1079-2019NORepinephrine 4 mg added to 5% Dextrose 250 mL Bag (PF), 4 mg / 250 mL, 250 mL IV bag, Rx only, KRS Global Biotechnology: 791 Park of Commerce Blvd., Boca Raton, FL 33487. NDC 3321674481; Lot: 12122018@7 Exp. 02/10/2019433 250 mL bags
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Verify the NDC code and lot number on the IV bag to confirm it is not the recalled version.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.1 years after the firm started it.

1. Firm started the recall: Jan 16, 201912. FDA classified it Class II: Apr 4, 201923. Published in FDA’s Enforcement Report: Apr 10, 201934. FDA terminated the recall: Feb 4, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product dangerous if used correctly?

No, the labeling mix-up does not make the product dangerous if used correctly. The risk is confusion in labeling.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1078-2019 (January 16, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1078-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA